GLYC
GlycoMimetics Inc
NASDAQ: GLYC · HEALTHCARE · BIOTECHNOLOGY
$0.16
+0.00% today
Updated 2026-04-30
Market cap
$10.13M
P/E ratio
—
P/S ratio
1,095.16x
EPS (TTM)
$-46.00
Dividend yield
—
52W range
$0 – $18
Volume
—
GlycoMimetics Inc (GLYC) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.81M | $15.26M | $3.99M | $15.03M | $20.07M | $18000.00 | $0.00 | $0.00 | $9.00M | $10.16M | $1.16M | $74925.00 | $10000.00 | $0.00 |
| Revenue growth (YoY) | — | +300.0% | -73.8% | +276.4% | +33.6% | -99.9% | -100.0% | — | — | +12.9% | -88.6% | -93.5% | -86.7% | -100.0% |
| Cost of revenue | $9.81M | $11.49M | $14.45M | $26.17M | $32.86M | $31.74M | $263541.00 | $275123.00 | $899302.00 | — | $1.01M | $1.03M | $153301.00 | $35174.00 |
| Gross profit | $3.81M | $15.26M | $3.99M | $15.03M | $20.07M | $18000.00 | $-263541.00 | $-275123.00 | $-899302.00 | $10.16M | $1.16M | $74925.00 | $10000.00 | — |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | — | — | -10.0% | 100.0% | 100.0% | 100.0% | 100.0% | — |
| R&D | $7.80M | $9.44M | $11.70M | $19.57M | $25.05M | $23.28M | $24.10M | $40.09M | $47.03M | $44.93M | $47.49M | $28.39M | $20.07M | $14.26M |
| SG&A | — | $2.16M | $2.90M | $6.60M | $7.80M | $8.65M | $9.83M | $11.41M | $14.36M | $16.74M | $17.11M | $19.09M | $19.21M | $18.25M |
| Operating income | $-6.08M | $3.66M | $-10.59M | $-11.14M | $-12.78M | $-31.91M | $-33.93M | $-51.51M | $-61.39M | $-51.51M | $-63.45M | $-47.40M | $-39.28M | $-32.51M |
| Operating margin | -159.5% | 24.0% | -265.2% | -74.1% | -63.7% | -177300.0% | — | — | -682.1% | -506.8% | -5469.6% | -63267.3% | -392752.9% | — |
| EBITDA | $-6.00M | $3.76M | $-10.47M | $-10.98M | $-12.59M | $-31.72M | $-33.67M | $-51.23M | $-61.11M | $-51.24M | $-63.18M | $-47.20M | $-39.12M | $-37.84M |
| EBITDA margin | -157.3% | 24.6% | -262.3% | -73.1% | -62.7% | -176241.4% | — | — | -679.0% | -504.2% | -5446.8% | -62990.8% | -391213.5% | — |
| EBIT | $-6.08M | $3.66M | $-10.61M | $-11.14M | $-12.78M | $-31.91M | $-33.93M | $-51.51M | $-61.39M | $-51.51M | $-63.45M | $-47.40M | $-39.27M | $-37.88M |
| Interest expense | $0.00 | $0.00 | $894000.00 | $18000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $20205.00 | $46.64M | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-6.11M | $3.66M | $-10.61M | $-11.12M | $-12.77M | $-31.81M | $-33.28M | $-48.27M | $-54.12M | $-50.27M | $-63.14M | $-93.33M | $-36.90M | $-37.88M |
| Net income growth (YoY) | — | +159.8% | -390.1% | -4.9% | -14.8% | -149.1% | -4.6% | -45.0% | -12.1% | +7.1% | -25.6% | -47.8% | +60.5% | -2.7% |
| Profit margin | -160.3% | 24.0% | -265.6% | -74.0% | -63.6% | -176722.2% | — | — | -601.3% | -494.7% | -5443.3% | -124562.7% | -368994.2% | — |